Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antidepressant “Black Box” Decision Imminent, FDA Tells Congress

Executive Summary

FDA will reach an internal decision on whether to request a "black box" warning on pediatric suicidality for all antidepressant labeling as early as the week of Sept. 27

You may also be interested in...



As Medication Guide Requirements Increase, FDA Considers Electronic Delivery

FDA is considering electronic distribution of Medication Guides as their use increases and questions are raised about whether they are consistently reaching patients

As Medication Guide Requirements Increase, FDA Considers Electronic Delivery

FDA is considering electronic distribution of Medication Guides as their use increases and questions are raised about whether they are consistently reaching patients

Antidepressant Fallout Includes Change In FDA Pediatric Study Procedure

Studies conducted under the Best Pharmaceuticals for Children Act will be included in labeling, FDA Office of Medical Policy Director Robert Temple, MD, told the House Energy & Commerce/Oversight Subcommittee Sept. 23

Related Content

Topics

UsernamePublicRestriction

Register

PS045148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel